Evaluation of the Effect of 5 QT-Positive Drugs on the JTpeak Interval - An Analysis of ECGs From the IQ-CSRC Study.

Journal of Clinical Pharmacology
Borje DarpoJean-Philippe Couderc

Abstract

The JTpeak interval has been proposed as a new biomarker to demonstrate mixed ion channel effects, potentially leading to reduced late-stage electrocardiogram (ECG) monitoring for mildly QT-prolonging drugs. ECG waveforms from the IQ-CSRC study were used. Twenty healthy subjects were enrolled with 6 subjects on placebo and 9 subjects on each of 5 mildly QT-prolonging drugs - moxifloxacin, dofetilide, ondansetron, dolasetron, and quinine - and 1 negative drug, levocetirizine. A vector magnitude lead was derived from 12-lead ECGs, and measurements were made on a median beat from three 10-second replicates. Data were analyzed using a linear concentration-response model with QTcF and heart rate corrected JTpeak (JTpeak_c) as dependent variables. For moxifloxacin, dofetilide, and ondansetron, all pure hERG blockers, slopes of the concentration (C)-QTcF and C-JTpeak_c relationships were positive and statistically significant. With the prespecified linear model, the predicted effects on ΔΔQTcF and ΔΔJTpeak_c were 11.4 and 9.4 milliseconds for moxifloxacin at the geometric mean Cmax on day 1, 9.0 and 11.7 milliseconds for dofetilide and 11.5, and 7.9 milliseconds for ondansetron, respectively. In contrast, dolasetron and quinine, both ...Continue Reading

References

Jul 12, 2002·Drugs·Peter M Haddad, Ian M Anderson
Apr 20, 2004·Journal of Cardiovascular Electrophysiology·Robert R FenichelUNKNOWN Independent Academic Task Force
Jul 3, 2013·Scientific Reports·James KramerArthur M Brown
Dec 18, 2013·Clinical Pharmacology and Therapeutics·L JohannesenD G Strauss
Jan 1, 2014·Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc·Borje DarpoNorman Stockbridge
Apr 15, 2015·Journal of the American Heart Association·Jose VicenteDavid G Strauss
Jul 15, 2015·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Borje DarpoNorman Stockbridge
Aug 12, 2015·Clinical Pharmacology and Therapeutics·L JohannesenD G Strauss
Apr 10, 2016·Journal of Pharmacological and Toxicological Methods·William J CrumbDavid G Strauss
Feb 18, 2017·Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc·Yuka TakeuchiTadayoshi Hata
Oct 13, 2017·Journal of Electrocardiology·Jean-Philippe CoudercMathias Baumert
Dec 7, 2017·Journal of Pharmacokinetics and Pharmacodynamics·Christine GarnettYaning Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Related Papers

Journal of Pharmacological and Toxicological Methods
Borje Darpo, Jean-Philippe Couderc
Drug Safety : an International Journal of Medical Toxicology and Drug Experience
Borje DarpoNorman Stockbridge
Journal of Pharmacological and Toxicological Methods
Ryuichi KomatsuJapan activity for Improvement of Cardiovascular Evaluation by Telemetry system (J-ICET)
© 2021 Meta ULC. All rights reserved